Compare NMRA & NWS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NMRA | NWS |
|---|---|---|
| Founded | 2019 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Newspapers/Magazines |
| Sector | | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 424.4M | 17.0B |
| IPO Year | 2023 | N/A |
| Metric | NMRA | NWS |
|---|---|---|
| Price | $3.16 | $25.97 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 5 |
| Target Price | $8.00 | ★ $37.94 |
| AVG Volume (30 Days) | ★ 1.7M | 1.6M |
| Earning Date | 03-02-2026 | 02-05-2026 |
| Dividend Yield | N/A | ★ 0.78% |
| EPS Growth | N/A | ★ 178.51 |
| EPS | N/A | ★ 2.02 |
| Revenue | N/A | ★ $8,624,000,000.00 |
| Revenue This Year | N/A | $5.12 |
| Revenue Next Year | N/A | $3.39 |
| P/E Ratio | ★ N/A | $12.67 |
| Revenue Growth | N/A | ★ 2.42 |
| 52 Week Low | $0.61 | $25.51 |
| 52 Week High | $3.47 | $35.58 |
| Indicator | NMRA | NWS |
|---|---|---|
| Relative Strength Index (RSI) | 80.32 | 28.05 |
| Support Level | $1.91 | $25.51 |
| Resistance Level | $3.47 | $27.41 |
| Average True Range (ATR) | 0.23 | 0.92 |
| MACD | 0.14 | -0.45 |
| Stochastic Oscillator | 87.78 | 1.36 |
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.
News Corporation is a diversified media conglomerate with large presence in the US, the UK, and Australia. Key mastheads include The Wall Street Journal, Barron's, New York Post, The Times, The Sun, The Australian, Herald Sun, and The Daily Telegraph. Its 61%-owned REA Group is the dominant property listings platform in Australia. In addition, it owns Harper Collins, one of the largest book publishers in the world, and has a sizable US digital property advertising business, Move. The 65% interest in Foxtel, the Australian pay-TV and streaming provider, was sold in April 2025. The sale to global sports streaming platform, DAZN, was struck at more than 7 times Foxtel's EBITDA.